Literature DB >> 9716492

Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.

K Lehti1, J Lohi, H Valtanen, J Keski-Oja.   

Abstract

Human fibroblasts and HT-1080 fibrosarcoma cells express membrane-type-1 matrix metalloproteinase (MT1-MMP), the cell surface activator of gelatinase A, in separate forms of 63 kDa, 60 kDa and in some cases 43 kDa. In the present work the interrelationships between MT1-MMP processing and gelatinase A activation were analysed using HT-1080 fibrosarcoma cells as a model. It was found that MT1-MMP was synthesized as a 63 kDa protein, which was constitutively processed to a 60 kDa active enzyme with N-terminal Tyr112, as shown by immunoprecipitation, immunoblotting and sequence analyses. Co-immunoprecipitation results indicated that only the active 60 kDa form of MT1-MMP bound gelatinase A at the cell surface. Both the activation of pro-MT1-MMP and the membrane binding of the tissue inhibitor of metalloproteinases type 2 (TIMP-2) and gelatinase A, and subsequent activation of gelatinase A, were inhibited by calcium ionophores. Although the active MT1-MMP was required for cell surface binding and activation of gelatinase A, it was inefficient in activating gelatinase A in fibroblasts or in control HT-1080 cells alone. Low expression levels of TIMP-2 and rapid synthesis of MT1-MMP were found to be critical for gelatinase A activation. In HT-1080 cells, MT1-MMP was further processed to an inactive, 43 kDa cell surface form when overexpressed, or when the cells were treated with PMA. Under these conditions, the activated gelatinase A was detected in the culture medium, in cell membrane extracts and in MT1-MMP-containing complexes. These results indicate that proteolytic processing (activation and degradation/inactivation) of MT1-MMP and MT1-MMP/TIMP-2 relationships at the cell surface are important regulatory levels in the control of gelatinolytic activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9716492      PMCID: PMC1219696          DOI: 10.1042/bj3340345

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

1.  Cell surface binding of TIMP-2 and pro-MMP-2/TIMP-2 complex.

Authors:  M R Emmert-Buck; H P Emonard; M L Corcoran; H C Krutzsch; J M Foidart; W G Stetler-Stevenson
Journal:  FEBS Lett       Date:  1995-05-01       Impact factor: 4.124

Review 2.  Biology and biochemistry of proteinases in tumor invasion.

Authors:  P Mignatti; D B Rifkin
Journal:  Physiol Rev       Date:  1993-01       Impact factor: 37.312

3.  Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.

Authors:  A Okada; J P Bellocq; N Rouyer; M P Chenard; M C Rio; P Chambon; P Basset
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

4.  Expression of membrane-type matrix metalloproteinase in human gastric carcinomas.

Authors:  H Nomura; H Sato; M Seiki; M Mai; Y Okada
Journal:  Cancer Res       Date:  1995-08-01       Impact factor: 12.701

5.  Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts.

Authors:  R V Ward; S J Atkinson; J J Reynolds; G Murphy
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

6.  Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease.

Authors:  A Y Strongin; I Collier; G Bannikov; B L Marmer; G A Grant; G I Goldberg
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

7.  Cellular activation of the 72 kDa type IV procollagenase/TIMP-2 complex.

Authors:  P D Brown; D E Kleiner; E J Unsworth; W G Stetler-Stevenson
Journal:  Kidney Int       Date:  1993-01       Impact factor: 10.612

8.  Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells.

Authors:  M Yu; H Sato; M Seiki; E W Thompson
Journal:  Cancer Res       Date:  1995-08-01       Impact factor: 12.701

9.  The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation.

Authors:  J Cao; H Sato; T Takino; M Seiki
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

10.  A plasma membrane-associated component of ovarian adenocarcinoma cells enhances the catalytic efficiency of matrix metalloproteinase-2.

Authors:  T N Young; S V Pizzo; M S Stack
Journal:  J Biol Chem       Date:  1995-01-20       Impact factor: 5.157

View more
  54 in total

1.  Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis.

Authors:  A Jiang; K Lehti; X Wang; S J Weiss; J Keski-Oja; D Pei
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

2.  Calmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells.

Authors:  B Annabi; A Pilorget; N Bousquet-Gagnon; D Gingras; R Béliveau
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

Review 3.  Liver repopulation and carcinogenesis: two sides of the same coin?

Authors:  Fabio Marongiu; Silvia Doratiotto; Stefania Montisci; Paolo Pani; Ezio Laconi
Journal:  Am J Pathol       Date:  2008-03-05       Impact factor: 4.307

4.  Mechanism of metastasis by membrane type 1-matrix metalloproteinase in hepatocellular carcinoma.

Authors:  Ying-Chi Ip; Siu-Tim Cheung; Ka-Ling Leung; Sheung-Tat Fan
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

5.  Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma.

Authors:  Brenda L Petrella; Jouko Lohi; Constance E Brinckerhoff
Journal:  Oncogene       Date:  2005-02-03       Impact factor: 9.867

6.  Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor.

Authors:  E Toschi; G Barillari; C Sgadari; I Bacigalupo; A Cereseto; D Carlei; C Palladino; C Zietz; P Leone; M Stürzl; S Buttò; A Cafaro; P Monini; B Ensoli
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

7.  Immunolocalization of matrix metalloproteinases and their inhibitors in clinical specimens of bone metastasis from breast carcinoma.

Authors:  S Lhoták; L J Elavathil; S Vukmirović-Popović; W C Duivenvoorden; R G Tozer; G Singh
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

8.  Culture of human cervical cancer cells, SiHa, in the presence of fibronectin activates MMP-2.

Authors:  Aparna Mitra; Jayati Chakrabarti; Aniruddha Banerji; Shamik Das; Amitava Chatterjee
Journal:  J Cancer Res Clin Oncol       Date:  2006-04-26       Impact factor: 4.553

9.  Expression and activity of matrix metalloproteinases-2 and -9 in serum, core needle biopsies and tissue specimens of prostate cancer patients.

Authors:  Christian G Sauer; Alexandra Kappeler; Monika Späth; Jens J Kaden; Maurice S Michel; Doris Mayer; Uwe Bleyl; Rainer Grobholz
Journal:  Virchows Arch       Date:  2004-04-16       Impact factor: 4.064

10.  Pervanadate-induced shedding of the intercellular adhesion molecule (ICAM)-1 ectodomain is mediated by membrane type-1 matrix metalloproteinase (MT1-MMP).

Authors:  E Essick; S Sithu; W Dean; S D'Souza
Journal:  Mol Cell Biochem       Date:  2008-05-03       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.